Previsioni

Il prezzo obiettivo medio degli analisti è 26,32 €. La mediana è 26,32 €.

Acquista	2
Mantieni	0
Vendi	0

Notizie Vai al feed delle notizie

FitLife Brands boosts revenue significantly and raises earnings per share

FitLife Brands released results for the most recent quarter: earnings per share were $0.20 versus $0.18 in the year‑ago quarter. Revenue rose to $26.6 million from $16.1 million in the prior‑year period. The figures indicate marked growth in both revenue and profitability. » Altro su finanzen.net
FitLife Brands beats Q2 forecasts, stock rises 9%

FitLife Brands reported adjusted EPS of $0.20 and revenue of $26.55 million for Q2 2026, beating consensus estimates. Revenue rose 65% year over year, driven by strong wholesale and online growth, while gross margin fell to 37.0% — mainly due to the lower-margin Irwin Naturals business. The company further reduced debt, improved EBITDA and net income, and announced supply-chain optimization measures and new products, but did not provide a formal revenue or earnings forecast. The stock rose 9.06% in regular trading and remained stable after hours. » Altro su de.investing.com
FitLife Brands reports weak Q4 online sales as Amazon algorithm changes and high whey prices hit margins

Alluvial Capital Management said FitLife Brands reported disappointing Q4 2025 results driven by continued declines in legacy online sales after changes to Amazon’s search algorithm and margin pressure from high whey protein costs. Gross profit less advertising from legacy products fell 18% year-over-year, and MusclePharm sales and margins were negatively affected. The company is adjusting marketing and launching new in-store products, while its August 2025 acquisition Irwin Naturals is growing online sales and generating cash above acquisition-related debt service. » Altro su finance.yahoo.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, FITLIFE BRANDS DL-,001 ha registrato ricavi pari a 23,26 Mln € e un utile netto di 1,71 Mln €

(EUR)	giu 2026	YoY
Ricavi	23,26 Mln	70,02%
Utile lordo	8,6 Mln	46,76%
Utile netto	1,71 Mln	15,28%
EBITDA	3,17 Mln	42,66%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	81,87 Mln €
Numero di azioni	9,39 Mln
Massimo/minimo a 52 settimane	18,11 € - 7,48 €
Dividendi	No
Beta	0,00
Rapporto P/E	15,30
Rapporto PEG	-0,66
Rapporto P/B	2,00
Rapporto P/S	0,94

Profilo aziendale

FitLife Brands, Inc. bietet Nahrungsergänzungsmittel für gesundheitsbewusste Verbraucher in den Vereinigten Staaten und international an. Das Unternehmen bietet Nahrungsergänzungsmittel zur Gewichtsabnahme, für die allgemeine Gesundheit und Sporternährung, Präzisions-Sporternährungsprodukte für den professionellen Muskelaufbau, leistungssteigernde Nahrungsergänzungsmittel zur Gewichtsabnahme und Sporternährung für Fitness-Enthusiasten, Gesundheits- und Gewichtsabnahmeprodukte für Männer sowie andere Diät-, Gesundheits- und Sporternährungsergänzungsmittel und verwandte Produkte, Sporternährungsprodukte, Energie- und Gewichtsabnahmeprodukte und Mahlzeitenersatz. Das Unternehmen vertreibt seine Produkte unter den Markennamen NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories und Energize in Franchise-Geschäften sowie in verschiedenen Einzelhandelsgeschäften, darunter Fachgeschäfte, Großmärkte und online. Das Unternehmen war früher als Bond Laboratories, Inc. bekannt und änderte im September 2013 seinen Namen in FitLife Brands, Inc. FitLife Brands, Inc. wurde im Jahr 2005 gegründet und hat seinen Hauptsitz in Omaha, Nebraska.

Nome	FITLIFE BRANDS DL-,001
CEO	Dayton Robert Judd
Sede centrale	Omaha, ne Stati Uniti
Sito web	fitlifebrands.com
Settore	Beni di prima necessità
Industria	Prodotti per la cura della persona
Quotazione in borsa	02/11/2007
Dipendenti	81